Diphenylsulfones such as 4, 4'-diaminodiphenylsulfone (DDS) are currently used in the chemotherapy of leprosy (19) and malaria (9, 11) . Both the antibacterial and antimalarial activities of DDS (3, 8, 13) , like those of the sulfonamides (14, 15, 25) , can be reversed by p-aminobenzoic acid (PABA). Dihydropteroate synthetase catalyzes the synthesis of dihydropteroate from 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphate and PABA. Although it is generally assumed that, as with the sulfonamides (6), the target enzyme of the sulfones is the synthetase, definitive studies on the action of sulfones on the isolated enzyme have not yet been reported. We have now examined the inhibitory action of several diphenylsulfones on the in vitro enzymatic synthesis of dihydropteroate, using a partially purified enzyme from Escherichia coli. A comparison is made between the inhibitory activities of various sulfones and sulfonamides and the reversal of this activity by PABA. MATERIALS (21) . This material was prepared fresh prior to each experiment. Formation of the dihydro compound was assessed by examination of the ultraviolet absorption spectrum (21, 22) . The concentration of dihydropteridine compounds was determined at 330 nm (pH 7.1), with the use of a molar extinction coefficient of 6,200 (21) .
Purification of dihydropteroate synthetase. Unless otherwise noted, all of the following steps were performed at 4 C.
Cell-free extracts were prepared by modifications of the procedures of Weisman and Brown (24) and Shiota (21) . A 30-g amount of frozen cells (E. coli B) was suspended in 5 volumes of cold 0.05 M Trishydrochloride buffer, pH 8.0. This suspension was passed twice through a French pressure cell (Aminco) at 15,000 to 20,000 psi. The disrupted cells were centrifuged for 20 min at 91,000 x g. The turbid supernatant solution was stored frozen for 16 h and centrifuged as above after thawing.
The supernatant material was treated with deoxyribonuclease (5 mg/100 ml) to decrease the viscosity. This solution was stirred for 30 min and centrifuged for 1 h at 118,000 x g.
Ribonuclease (1 gg of protein/ml) was added to the deoxyribonuclease-treated supernatant fluid. This solution was incubated in a bath at 37 C for 1 h with occasional mixing. The cloudy solution was centrifuged at 91,000 x g for 20 min to remove insoluble material.
The supernatant solution was then fractionated with ammonium sulfate by slowly adding solid ammonium sulfate (11.4 g/100 ml) to achieve a 20% saturation at 4 C. The mixture was stirred for 1 h and centrifuged for 1 h at 27,000 x g. Ammonium sulfate (34 g/100 ml) was added to the supernatant solution to achieve a 70% saturation at 4 C. The mixture was stirred for 1 h and centrifuged for 1 h at 27,000 x g. The precipitate was then dissolved in 20 ml of 0.05 M Tris-hydrochloride buffer, pH 8.0, and was dialyzed for 36 h against the same buffer (three changes of 6 liters of buffer). The dialyzed material was then centrifuged for 1 h at 118,000 x g. The clear extract was applied to a column of Sephadex G-25 (2.5 by 60 cm) which had been equilibrated with 0.05 M Tris-hydrochloride buffer, pH 8 .0. The same buffer was used to elute the enzyme from the column. The initial protein eluates were combined and used as the dihydropteroate synthesizing extract.
Assay of dihydropteroate synthetase activity. Dihydropteroate synthetase activity was measured by a modification of the radioactive assay of Richey and Brown (16) , based on the incorporation of "C-PABA into dihydropteroate. Each reaction mixture was prepared to contain in a volume of 0.4 ml/ Tris-hydrochloride buffer, pH 8.5, 100 mM; MgCl2, 10 mM; 2-mercaptoethanol, 50 mM; hydroxymethyldihydropteridine pyrophosphate, 0.12 mM; "4C-PABA, 0.01 mM; inhibitor, as indicated; and partially purified dihydropteroate synthetase extract, 0.2 mg. Blank determinations contained all components except enzyme. The reaction mixtures, contained in test tubes (1 by 7 cm), were stoppered and incubated for 1 h at 37 C. The reactions were stopped immediately by the addition of 25 25 C. Under these conditions, pteroate (dihydropteroate is oxidized to pteroate during the evaporation step) remains at the origin, whereas unreacted 14C-PABA migrates with an Rf value of 0.78. Areas corresponding to the origin of the developed chromatograms were cut out and counted in a liquid scintillation counter. All enzyme assays were done in triplicate. Enzyme activity is expressed as picomoles of dihydropteroate produced per hour.
The concentration of various sulfones and sulfonamides required for 50% inhibition (I,,) of dihydropteroate synthetase activity was determined by titration of at least five levels of drug in the standard reaction system. Analysis of kinetic data. The values of the inhibition constants (K,) together with their standard errors were determined by fitting the primary data for each experiment to the overall rate equation for linear competitive inhibition through the use of the Fortran programs of Cleland (7) and a digital computer. The points drawn in the kinetic figures showing double reciprocal plots are an average of three experimentally determined values. In general, the error of the individually determined values was less than 10% of the average value reported.
RESULTS
Comparative effects of sulfones and sulfonamides on dihydropteroate synthetase. Table   1 shows the 1,g0 values of several sulfones and sulfonamides determined against dihydropteroate synthetase. Of a number of sulfones that prevented us from testing concentrations greater than 10-4 M. These results would indicate that only those diphenylsulfone congeners having a free arylamine group are effective inhibitors of dihydropteroate synthetase.
Of a number of sulfonamides that have been tested, sulfadiazine (I50 = 10-5 M) was the most potent inhibitor, whereas sulfanilamide (I50 = 3.2 x 10-4 M) was a relatively poor inhibitor. These results are in agreement with those previously reported by Brown (6) , who also determined the Km for PABA (2.5 x 10-6 M) for this enzyme (16) . A comparison of the inhibitory properties of the sulfones and the sulfonamides shows the most active sulfone, DDS, to be half as active as sulfadiazine. It has been reported that substitution of the 4-amino group of sulfanilamide by an aminomethyl group (NH2-CH2-) results in a compound, homosulfanilamide, having antibacterial action which is not antagonized by PABA (5). It was of interest, therefore, to test the effect of this compound on dihydropteroate synthetase activity in vitro. No inhibition was observed with concentrations of homosulfanilamide as high as 10-2 M (Table 1) .
Reversal by PABA of DDS and sulfadiazine inhibition. A reciprocal plot of dihydropteroate synthetase activity versus substrate concentration at two levels of DDS is shown in Fig. 1A . A pattern of competitive inhibition was obtained by DDS with respect to PABA. These findings are in accord with previous reports on the reversal by PABA of the antibacterial activity of DDS (13) . As shown in Fig. 1B (17) .
DISCUSSION
The data show that the diaminodiphenylsulfones, like the sulfonamides, are effective inhibitors of dihydropteroate synthetase in vitro. Of particular importance is the demonstration that a free arylamine group of the parent sulfone is required for inhibitory activity. This substantiates previous conclusions that the antimalarial efficacy of 4,4'-diformamidodiphenylsulfone in P. berhei (23) (20, 23) are due to the conversion to DDS.
The competitive inhibition of dihydropteroate synthetase by the sulfones with respect to PABA suggests that, like the sulfonamides (6), these compounds are acting as a structural analogue of PABA and are thereby competing for the active site of the enzyme. Bell and Roblin (2) in 1942 pointed out the structural similarity between the SO, group of the sulfones and sulfonamides and the C02-ion of PABA. They postulated that the antibacterial activity of the PABA antagonists depended upon the negativity of the SO2 group. They used the acid dissociation constant (pK.) as an indirect measure of the negative character of the SO2 group and showed that the activity of a group of N1-substituted sulfonamides was related to the acid dissociation constants of the sulfonamido groups. Plotting the minimal inhibitory concentration (MIC) for E. coli against the acid dissociation constant (pK.) values of the sulfonamides, Bell and Roblin found a bell-shaped curve with the lowest MIC at pK. 6.7 . Although this relation between pK. and activity has been widely used as a prediction and reflection of potency in this series, it must be pointed out that the fundamental point of Bell and Roblin concerned negativity of the SO2 group. This property, through an inductive effect, influences both the basicity of the aromatic amine and (in the case of sulfonamides) the acidity of the sulfonamide proton. In DDS, the latter is lacking; however, its basic pK. of 2 is similar to the basic pKa of the active sulfonamides (18, 26) . These basic pK. values have too narrow a range (about 0.3 unit) to account for the wide (about 100-fold) variation in activity between, for example, sulfanilamide and DDS -sulfadiazine. Thus, it appears that neither acid nor basic properties alone can explain the activity in this group of drugs. The. high potency of DDS as a PABA competitor probably is based on steric factors that remain to be explained.
The lack of inhibition of dihydropteroate synthetase by homosulfanilamide is in agreement with previous observations that the antibacterial action of this compound is not antagonized by PABA (10) .
